Krystal Biotech Files 8-K for Regulation FD Disclosure
Ticker: KRYS · Form: 8-K · Filed: Jul 9, 2025 · CIK: 1711279
| Field | Detail |
|---|---|
| Company | Krystal Biotech, Inc. (KRYS) |
| Form Type | 8-K |
| Filed Date | Jul 9, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: disclosure, regulation-fd
Related Tickers: KRYS
TL;DR
Krystal Biotech filed an 8-K for a Reg FD disclosure on 7/9/25.
AI Summary
Krystal Biotech, Inc. filed an 8-K on July 9, 2025, to report a Regulation FD Disclosure. The filing does not contain specific financial figures or event details beyond the disclosure type and date.
Why It Matters
This filing indicates Krystal Biotech is making a public disclosure under Regulation FD, which ensures all investors receive material information simultaneously.
Risk Assessment
Risk Level: low — The filing is a standard procedural disclosure without new material financial or operational information.
Key Players & Entities
- Krystal Biotech, Inc. (company) — Registrant
- July 9, 2025 (date) — Date of earliest event reported
- Regulation FD (regulation) — Type of disclosure
FAQ
What is the specific nature of the Regulation FD Disclosure being made by Krystal Biotech?
The filing does not specify the exact nature of the Regulation FD Disclosure, only that one is being made.
When was the earliest event reported in this 8-K filing?
The earliest event reported is July 9, 2025.
What is Krystal Biotech's principal executive office address?
Krystal Biotech's principal executive offices are located at 2100 Wharton Street, Suite 701, Pittsburgh, Pennsylvania 15203.
Under which section of the Securities Exchange Act of 1934 is this 8-K filed?
This 8-K is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
What is Krystal Biotech's IRS Employer Identification Number?
Krystal Biotech's IRS Employer Identification Number is 82-1080209.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 9, 2025 regarding Krystal Biotech, Inc. (KRYS).